KORU Medical Systems Q1 Earnings Call Highlights
MarketBeat
KORU Medical Systems (NASDAQ:KRMD) reported a “record start to the year” in the first quarter of 2026, posting revenue of $11.8 million, up 22% from the prior-year period, as the company pointed to domestic share gains in subcutaneous immunoglobulin (SCIg), accelerating international growth tied to
NASDAQ:KRMD